Phase 2 Autoimmune Encephalitis Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease
Autoimmune EncephalitisAnti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE)Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease
Arialys Australia Pty Ltd30 enrolled1 locationNCT07093333
Recruiting
Phase 2
Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?
Autoimmune Encephalitis (AE)
University Hospital, Toulouse40 enrolled1 locationNCT07488117
Recruiting
Phase 2
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis
Autoimmune Encephalitis
Jena University Hospital50 enrolled17 locationsNCT03993262
Recruiting
Phase 2
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
EncephalitisAutoimmune Encephalitis
University of Utah116 enrolled39 locationsNCT04372615
Recruiting
Phase 2
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
Autoimmune EncephalitisPsychosis
University of Cambridge70 enrolled10 locationsNCT03194815